- Home
- JANX vs SAND Comparison
JANX vs SAND Comparison
Compare JANX & SAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- SAND
- Stock Information
- Founded
- JANX 2017
- SAND 2007
- Country
- JANX United States
- SAND Canada
- Employees
- JANX N/A
- SAND N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- SAND
- Sector
- JANX Health Care
- SAND
- Exchange
- JANX Nasdaq
- SAND NYSE
- Market Cap
- JANX 2.2B
- SAND 1.9B
- IPO Year
- JANX 2021
- SAND N/A
- Fundamental
- Price
- JANX $26.81
- SAND $7.49
- Analyst Decision
- JANX Strong Buy
- SAND Buy
- Analyst Count
- JANX 8
- SAND 3
- Target Price
- JANX $91.25
- SAND $9.42
- AVG Volume (30 Days)
- JANX 784.7K
- SAND 4.2M
- Earning Date
- JANX 05-06-2025
- SAND 05-01-2025
- Dividend Yield
- JANX N/A
- SAND 0.70%
- EPS Growth
- JANX N/A
- SAND N/A
- EPS
- JANX N/A
- SAND 0.05
- Revenue
- JANX $10,588,000.00
- SAND $176,283,000.00
- Revenue This Year
- JANX N/A
- SAND $12.83
- Revenue Next Year
- JANX $289.47
- SAND $12.67
- P/E Ratio
- JANX N/A
- SAND $155.90
- Revenue Growth
- JANX 30.99
- SAND N/A
- 52 Week Low
- JANX $26.39
- SAND $4.92
- 52 Week High
- JANX $71.71
- SAND $7.74
- Technical
- Relative Strength Index (RSI)
- JANX 29.87
- SAND 70.99
- Support Level
- JANX $29.77
- SAND $7.37
- Resistance Level
- JANX $32.00
- SAND $7.74
- Average True Range (ATR)
- JANX 1.44
- SAND 0.21
- MACD
- JANX -0.00
- SAND 0.08
- Stochastic Oscillator
- JANX 7.01
- SAND 82.29
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
About SAND SANDSTORM GOLD LIMITED
Sandstorm Gold Ltd provides financing to companies engaged in gold mining through the gold stream and royalty. Geographically, the company has operational footprints in North America, South & Central America, Africa, and Asia & Australia. The firm's royalties include Hod Maden, Santa Elena, Chapada, Platreef, Greenstone, and Cerro Moro.